Artivion, Inc. (AORT)
Sector: Healthcare
Industry: Surgical & Medical Instruments & Apparatus
Country: United States
Exchange: NYSE
Market cap: $1.14B
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
Latest financial period: June 30, 2026
Filed with the SEC: August 7, 2026
Estimated earnings date: November 5, 2026
Profit #1205 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROIC | 2.2% | 3.6% | 4.5% | 3.9% |
Growth #207 of 1484 companies
Payout #1117 of 1484 companies
Safety #1158 of 1484 companies
Price #1346 of 1484 companies
